Physician profile
George C Parides
NPI 1851379879
$912,624.26
in general payments reported to CMS, 2019-2025
54 companies · $132K in 2025
The $132K reported for 2025 was more than what 99% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63K · 2020: $24K · 2021: $169K · 2022: $184K · 2023: $170K · 2024: $171K · 2025: $132K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $404K · Travel and Lodging: $46K · Food and Beverage: $14K · Consulting Fee: $9,533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $404,218.00 |
| Travel and Lodging | $45,875.60 |
| Food and Beverage | $13,852.80 |
| Consulting Fee | $9,532.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $833,351.11 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Mylan Specialty L.P. | $71,072.38 | 2019-2024 | Yupelri, Yupelri |
| Verona Pharma, INC. | $2,000.00 | 2025 | Ohtuvayre |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $570.71 | 2019-2023 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $494.14 | 2019-2024 | Jardiance |
| Glaxosmithkline, LLC. | $475.79 | 2019-2024 | Trelegy Ellipta, Nucala |
| Grifols USA, LLC | $431.99 | 2019-2022 | |
| Gilead Sciences, INC. | $379.96 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $292.38 | 2021-2024 | Dupixent |
| Abbvie INC. | $291.81 | 2019-2024 | |
| Philips North America LLC | $242.07 | 2019-2021 | |
| Janssen Biotech, INC. | $221.99 | 2019-2024 | Stelara |
| United Therapeutics Corporation | $205.15 | 2021-2024 | Tyvaso |
| Ardelyx, INC. | $198.21 | 2022-2023 | Ibsrela |
| Actelion Pharmaceuticals US, INC. | $181.04 | 2019-2024 | Opsumit |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $176.07 | 2019-2024 | Repatha, Otezla, Evenity |
| Genzyme Corporation | $167.11 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $152.76 | 2021-2024 | Zerbaxa, Dificid, Recarbrio |
| Celgene Corporation | $130.54 | 2021-2022 | |
| Baxter Healthcare | $129.64 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| Abbott Laboratories | $104.09 | 2022-2023 | Proclaim, Octrode |
| Takeda Pharmaceuticals U.S.A., INC. | $103.88 | 2020-2023 | Gattex |
| Daiichi Sankyo INC. | $100.43 | 2019-2024 | Injectafer |
| Inspire Medical Systems, INC. | $97.08 | 2023-2024 | Inspire |
| Ironwood Pharmaceuticals, INC | $94.26 | 2019-2023 | Linzess |
| Novartis Pharmaceuticals Corporation | $77.21 | 2021-2024 | |
| Insmed, INC. | $76.48 | 2021-2023 | Arikayce |
| Advanced Respiratory, INC | $75.31 | 2020-2021 | |
| Mylan Institutional INC. | $75.20 | 2023 | Hulio |
| Genentech USA, INC. | $64.76 | 2019-2023 | Xolair |
| Redhill Biopharma INC. | $60.51 | 2020-2021 | |
| Covis Pharma Gmbh | $51.38 | 2021-2023 | |
| Sanofi Pasteur INC. | $47.35 | 2019-2023 | |
| Braintree Laboratories, INC. | $45.80 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $39.28 | 2019 | |
| Fresenius Kabi USA, LLC | $30.52 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $30.13 | 2021 | |
| Boston Scientific Corporation | $29.30 | 2021 | |
| Janssen Pharmaceuticals, INC | $25.85 | 2019 | |
| Tactile Systems Technology INC | $25.07 | 2023 | Entre Plus, Flexitouch Plus |
| Dexcom, INC. | $24.33 | 2023 | Dexcom G6 Transmitter |
| Electromed, INC. | $19.02 | 2021 | |
| Intercept Pharmaceuticals, INC. | $17.73 | 2020 | |
| Exact Sciences Corporation | $16.02 | 2023 | Cologuard Collection Kit |
| Novo Nordisk INC | $15.96 | 2019 | |
| Oxford Immunotec USA INC | $14.45 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.13 | 2021 | |
| Shire North American Group INC | $14.11 | 2019 | |
| Axonics, INC. | $14.02 | 2021 | |
| Impulse Dynamics (USA) INC. | $13.62 | 2023 | Optimizer |
| Hologic Sales and Service, LLC | $13.24 | 2019 | |
| Phadia US INC. | $11.59 | 2019 | |
| Lilly USA, LLC | $11.19 | 2019 | |
| Inogen, INC. | $6.11 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Parides listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.